Gut check: bacteria may reveal who will respond to arthritis biologics
NCT ID NCT04899154
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study looks at whether the types of bacteria in your gut can predict how well you will respond to biologic treatments for spondyloarthritis, a type of inflammatory arthritis. Researchers will compare the gut bacteria of 80 people starting biotherapy (anti-TNF or anti-IL17) and see if those who respond have a different bacterial makeup than those who do not. The goal is to help doctors choose the right treatment from the start, avoiding ineffective therapies and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPONDYLOARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Européen Marseille
RECRUITINGMarseille, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.